Literature DB >> 23207930

Colorectal cancer screening: practice guidelines.

David Lieberman1.   

Abstract

Colorectal cancer (CRC) screening has been demonstrated to reduce both incidence and mortality of CRC. There are several different screening options, each with potential benefits and some limitations. Fecal blood tests are primarily early cancer detection tests, which have been shown to reduce CRC mortality. Structural exams of the colon (flexible sigmoidoscopy, colonoscopy and imaging) may identify cancer precursor lesions (adenomas) and early cancer. There is evidence that detection and removal of adenomas may prevent many cancers. New forms of screening using stool DNA, capsule endoscopy and serum testing for genetic mutations are still in evolution, though proof-of-principle studies have been published.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2012        PMID: 23207930     DOI: 10.1159/000341891

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  8 in total

1.  The value of preoperative screening colonoscopies in patients with biliary tract cancer.

Authors:  Keita Itatsu; Yukihiro Yokoyama; Tomoki Ebata; Tsuyoshi Igami; Gen Sugawara; Keisuke Uehara; Takashi Mizuno; Masahiko Ando; Hidemi Goto; Masato Nagino
Journal:  J Gastroenterol       Date:  2015-05-31       Impact factor: 7.527

2.  Promoting colorectal cancer screening through group education in community-based settings.

Authors:  Danielle M Crookes; Ogo Njoku; Maria Carina Rodriguez; Elsa Iris Mendez; Lina Jandorf
Journal:  J Cancer Educ       Date:  2014-06       Impact factor: 2.037

3.  Case of inappropriate ADH syndrome: hyponatremia due to polyethylene glycol bowel preparation.

Authors:  Sun-Hye Ko; Chul-Hyun Lim; Jae-Young Kim; Seung Hun Kang; Myong Ki Baeg; Hyun Jin Oh
Journal:  World J Gastroenterol       Date:  2014-09-14       Impact factor: 5.742

Review 4.  Colorectal cancer screening--optimizing current strategies and new directions.

Authors:  Ernst J Kuipers; Thomas Rösch; Michael Bretthauer
Journal:  Nat Rev Clin Oncol       Date:  2013-02-05       Impact factor: 66.675

Review 5.  Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives.

Authors:  Inês Marques; António Araújo; Ramon Andrade de Mello
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

6.  Longitudinal Liquid Biopsy and Mathematical Modeling of Clonal Evolution Forecast Time to Treatment Failure in the PROSPECT-C Phase II Colorectal Cancer Clinical Trial.

Authors:  Khurum H Khan; David Cunningham; Benjamin Werner; Georgios Vlachogiannis; Inmaculada Spiteri; Timon Heide; Javier Fernandez Mateos; Alexandra Vatsiou; Andrea Lampis; Mahnaz Darvish Damavandi; Hazel Lote; Ian Said Huntingford; Somaieh Hedayat; Ian Chau; Nina Tunariu; Giulia Mentrasti; Francesco Trevisani; Sheela Rao; Gayathri Anandappa; David Watkins; Naureen Starling; Janet Thomas; Clare Peckitt; Nasir Khan; Massimo Rugge; Ruwaida Begum; Blanka Hezelova; Annette Bryant; Thomas Jones; Paula Proszek; Matteo Fassan; Jens C Hahne; Michael Hubank; Chiara Braconi; Andrea Sottoriva; Nicola Valeri
Journal:  Cancer Discov       Date:  2018-08-30       Impact factor: 39.397

Review 7.  Mechanisms linking excess adiposity and carcinogenesis promotion.

Authors:  Ana I Pérez-Hernández; Victoria Catalán; Javier Gómez-Ambrosi; Amaia Rodríguez; Gema Frühbeck
Journal:  Front Endocrinol (Lausanne)       Date:  2014-05-01       Impact factor: 5.555

8.  Lack of Association between Red Meat Consumption and a Positive Fecal Immunochemical Colorectal Cancer Screening Test in Khon Kaen, Thailand: a Population- Based Randomized Controlled Trial

Authors:  Putthikrai Pramual; Pongdech Sarakarn; Siriporn Kamsa-ard; Chananya Jirapornkul; Naowarat Maneenin; Prasert Thavondunstid; Prachak Juntarach; Supannee Promthet
Journal:  Asian Pac J Cancer Prev       Date:  2018-01-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.